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I.

Executive Summary

The Problem:
It is well known that our country is experiencing an obesity epidemic: 33.9% of
all adults are obese (BMI>30) and 67% of adults are either overweight or obese
(BMI>25). Obesity is a risk factor for several serious disease states such as, diabetes,
stroke, hypertension, heart disease and some types of cancer. It also has a less well
defined relationship with skin and soft tissue infections.
Although it is known that excessive weight increases the opportunity for harmful
skin conditions, this relationship has not been as well studied. Some of the mechanisms
that predispose obese people to infections are known, but much of the interrelationship
remains uncertain especially its impact on health care cost and policy. This study
contributes to the limited knowledge on the relationship between obesity and skin and
soft tissue infections.
Research Strategy and Methods:
Using the H-CUP national data base for inpatient hospitalizations, this study
analyzed the data from the hospitals in several states in the South for the number of
skin and soft tissue infections for the years 2003, 2005, 2007. Using the co-morbidity
code for obesity, the proportion of patients who are also obese in this population was
quantified for each of the three years specified. Two linear regressions analyzed the
impact of obesity on the cost of health care by using length of stay and total hospital
charges as dependent variables.
Major Findings:
The proportion of patients hospitalized for skin and soft tissue infections that are
also obese has increased from 47.56% in 2003 to 50.42% in 2007. Surprisingly, the comorbidity of obesity has a negative predictive value for both hospital length of stay and
total hospital charges.
Recommendations for Further Studies:
This study is an initial evaluation of the relationship between obesity and skin
and soft tissue infections. More research is needed to determine whether obesity is a
causal factor in skin and soft tissue infections and how this is affecting the cost and
delivery of health care. Local, state and federal governments are beginning to create
policies aimed at addressing the obesity epidemic, but the research to support such
policies is in its infancy and requires more attention to be able to inform the policy
process adequately.
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II. The Problem Statement
It is well known that obesity can lead to other chronic disease states including
hypertension, type 2 diabetes, coronary heart disease, some cancers, hyperlipidemia
and osteoarthritis.1,2,3,4 Obesity is also known to be directly related to an increased risk
of gallbladder disease, stroke, infertility, sleep apnea and musculoskeletal disease.5,6,7,8,9
A 2008 study found that overweight and obese people were 16% more likely to
have dyslipideamia, 7% more likely to have heart disease, 14% more likely to have
hypertension, and 5% more likely to have sleep apnea.3 The obese individual has a 3.85
times greater risk of hospitalization than the non-obese person.10 Thompson found that
the risk of hypertension is about 2-fold higher and the risk for type 2 diabetes is almost
3 fold higher in the obese person.11 Also, nearly 60% of type 2 diabetes is attributable to
obesity.12 These co-morbidities contribute to the cost and also to the mortality and
morbidity of those who are overweight and obese.
The connection of obesity with skin and soft tissue disease is less well studied
than with other disease states. Wolf found from the PROCEED study that people who
are overweight or obese have an 8% greater prevalence of self-reported skin condition
symptoms than the person who has normal weight.3 Unfortunately, the types of skin
conditions were not defined in that study.
Some of the mechanisms that predispose obese people to infections are known,
but much of the interrelationship remains uncertain especially its impact on health care
cost and policy. This study attempts to illuminate one small piece of this puzzle.
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Using the H-CUP national data base for inpatient hospitalizations, I analyzed the
data from the hospitals in several states in the South for the number of skin and soft
tissue infections for the years 2003, 2005, 2007. Using the co-morbidity code for
obesity, I also found the proportion of patients who are also obese in this population
and track the trends for the three years specified. My hypothesis is that within the
population of patients who are admitted for skin and soft tissue infections, the
proportion of those who are also obese is increasing.
I have chosen to confine the research to hospitals in the South since this
information is more relevant to the state of Kentucky and also because the South’s rate
of obesity is rising more quickly than other regions of the United States.34 As such, if the
rate of obesity within this population is increasing, this is the region in which it will most
likely be found. The hospitals in the sample are a mix of large and mid-size hospitals so
as to capture urban and more rural areas of the states.
A secondary outcome is the cost of obesity related skin and soft tissue infections
using total hospital charges (Total Charges) and length of stay (LOS) as proxies for cost.
A regression analysis was completed using length of stay and another using Total
Charges as the dependent variables and age, gender of patient, median household
income quartiles for patient’s ZIP code, payer information, race and co-morbidity codes
as independent variables.
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III. Background
According to the CDC, the percent of obese adults in America (BMI>30) in 2006
was 33.9% and the percent of adults overweight (including obese) with a BMI>25 was
67%. Since the 1980-s each decade has brought an increasing prevalence of overweight
and obese adults.12,13 The latest research indicates that the prevalence of obesity seems
to be stabilizing at 33.8% overall among adults and the prevalence estimates for
overweight and obesity combined has stabilized at 68%.14
Encouragingly, the prevalence of a BMI for age at or above the 95th percentile
(what is considered “obese” in children) among children and adolescents has also
showed no significant changes between 1999 and 2006 except among the very heaviest
3-19 year old boys. However, it remains high at approximately 17%.15
This health issue touches all ethnic groups in all the states of the union and is
spreading to other industrialized nations as well.12,16 It is truly an epidemic which
demands the attention of health care policy not only for its impact on individual health
but also for its economic impact on the health care system.17
Unfortunately for Kentucky, the South is leading the country in these trends. As
such, the importance of understanding the impact of obesity carries even greater
significance and urgency. The cost of obesity and disease states induced by obesity is
truly staggering. Currently, the cost of obesity for the country is about $147 billion and
it now accounts for about 9.1% of medical spending. In Kentucky alone, the estimated
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direct health care costs associated with obesity in 2008 were $1.2 billion.35 According
to Wolf the mean health care costs of a person with a BMI of 20-24 (considered normal
weight) was $456 ± 937 compared to a person with a BMI of >30 which was $1186 ±
2808.3 Another study found that overall health care costs for overweight and obese
people were 37% higher than for people with normal weight.18
In 2001, the obesity-attributable costs of health insurance to US businesses were
estimated to account for 4.6% of total business spending on employee health
insurance.1 Also, it was found that mean annual medical-care costs were 36% higher
over nine years for people who were obese compared to people with normal BMIs.1 The
combination of the two major determinants of obesity, lack of physical activity and
excess caloric intake is now second only to smoking as the leading preventable cause of
death in the United States.19,20 Obesity is now responsible for more health care
expenditures, including direct and indirect costs, than any other contributory health
condition including smoking and problematic drinking.19,20
There are several mechanisms by which obesity increases the opportunity for
harmful skin conditions. Excessive fat folds favor humidity and maceration (the
breakdown of skin that is constantly kept wet) with bacterial and fungal overgrowth
which can lead to severe infections requiring hospitalization for treatment. The
pressure within skin folds can be sufficient in and of itself to cause skin breakdown and
secondary infection.21,22
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Obesity also impedes lymphatic flow, thus the accumulated protein-rich
lymphatic fluid decreases oxygenation of the surrounding tissue leading to fibrosis and a
chronic inflammatory state.5 This state provides a hospitable culture medium for
bacterial growth which can lead to serious infection. The pH of the skin is also higher in
people who are obese which is more conducive for candidal superinfections since
Candida thrives in alkaline environments.5
Obesity is also a risk factor for the development of chronic venous insufficiency
which is a risk factor for venous ulcerations.22 And since obesity decreases wound
healing by diminishing perfusion to the injured tissue, these ulcers tend to be more
severe and more difficult to treat. Increased tension on the wound edges from obesity
may further aggravate wound healing or lead to dehiscence (reopening of a closed
wound).22,23
In addition, obesity increases the incidence of several other more serious skin
conditions: erysipelas (an acute streptococcal skin infection), intertrigo (inflammation of
the skin folds), cellulitis (diffuse inflammation of connective tissue in the dermal and
subcutaneous layers), and necrotizing fasciitis (a rapidly spreading infection of the fascia
in the subcutaneous tissue due to toxins released by bacteria).22,24,25 One study
revealed that 88% of women hospitalized for necrotizing fasciitis were obese.26
This relationship between skin and soft tissue infections and obesity has not
garnered as much attention as other disease states related to obesity, but the current
research demonstrates that there is a relationship between the two. As the economic
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burden of obesity continues to have a significant impact on health care, this relationship
may prove to be a significant portion of the overall cost. This study is a preliminary
foray into the health care cost of obesity and skin and soft tissue infections.

IV. Research Strategy and Methods
The Sample
The data used for this project came from the Healthcare Cost and Utilization
Project (H-CUP) Nationwide Inpatient Sample (NIS) for the years 2003, 2005, 2007. The
year 2001 was originally to be used so as to give a greater spread of time to capture
more data for the proposed hypotheses; however, the 2001 data set did not include the
co-morbidity codes from the Disease Severity Measure files that were present in the
other years. As such, I would not be able to compare the data from 2003-2007 with
2001, so this data set was not used in the analysis.
The NIS is a database of hospital inpatient stays that includes charge information
on all patients regardless of payer and also includes clinical and resource use
information typically available from discharge abstracts. Each year of the NIS provides
information on approximately 5 million to 8 million inpatient stays from about 1,000
hospitals nationwide. The NIS is designed to approximate a 20-percent sample of U.S.
community hospitals (this includes specialty hospitals, public hospitals, private hospitals,
academic medical centers, acute care hospitals, but not short-term rehabilitation
hospitals, long-term non-acute care hospitals, psychiatric hospitals and
alcoholism/chemical dependency treatment facilities).
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For this study, only the data from the following states were used: Kentucky,
Georgia, North Carolina, South Carolina, Tennessee and West Virginia. These states
were chosen because data for them is present in all three years and they are in the
Southern region of the country. Mississippi, Alabama and Louisiana are not in the NIS
database, Virginia’s data for 2005 was not available and Arkansas’ data for 2003 was not
available. While Florida and Texas have data available for all three years, the population
in each of these states is substantially different than the general population of Kentucky.
The data for this research were chosen by selecting admission diagnosis ICD-9
codes (International Statistical Classification of Diseases and Related Health Problems
9th Revision) that indicated that the admission was due to a skin or soft tissue infection
for the states listed above. The following ICD-9 codes were used: 707 (chronic ulcer of
skin), 680-686 (infections of skin and subcutaneous tissue) and 728.86 (necrotizing
fasciitis).

Measures
The following data elements were selected for each record: age, diagnosis ICD-9
code, whether the patient died in the hospital, gender of patient, HCUP hospital
number, state postal code for the hospital, length of stay (LOS), median household
income quartiles for patient’s ZIP code, primary payer information, race, key record
identifier and total hospital charges (Total Charges).
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Table 1: Data elements from H-CUP Nationwide Inpatient Sample
Age
Female
LOS
Died
ZipQrtl

PAY
RACE
HOSPST
Cm_Arth

Cm_DM
Cm_Dmcx
Cm_HTN_c

Cm_Obese

Age in years coded 0-124 years
Dummy Variable. Indicates gender 0=male, 1=female
Length of stay in number of days
Dummy Variable. Indicates in-hospital heath: 0=did not die
during hospitalization, 1=died during hospitalization
Median household income quartiles for patient’s ZIP code.
1=$1-$38,999 2=$39,000-$47,999 3=$48,000-$62,999
4=$63,000 or more
Expected primary payer 1=Medicare, 2=Medicaid, 3=private
including HMO, 4=self-pay, 5=not charge
Race, uniform coding 1=white, 2=black, 3=Hispanic, 4=Asian or
pacific islander, 5= native American, 6=other
State postal code for the hospital (e.g. AZ for Arizona)
AHRQ co-morbidity measure: Rheumatoid arthritis/collagen
vascular diseases: 0=co-morbidity is not present 1-comorbidity is present
AHRQ co-morbidity measure: diabetes uncomplicated: 0=comorbidity is not present 1-co-morbidity
AHRQ co-morbidity measure: diabetes with chronic
complications: 0=co-morbidity is not present 1-co-morbidity
AHRQ co-morbidity measure Hypertension (combine
uncomplicated and complicated): 0=co-morbidity is not
present 1-co-morbidity
AHRQ co-morbidity measure: Obesity: 0=co-morbidity is not
present 1-co-morbidity

This selected data from the core files was then matched with data from the
Disease Severity Measure files for the following co-morbidity data elements:
rheumatoid arthritis/collagen vascular disease, diabetes, diabetes with chronic
complications, hypertension, and obesity. These co-morbidity data elements were
chosen because of their established relationship with obesity. The program used to
analyze the data was STATA 11.
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Procedures/ Statistical Tests
The percentage of admissions for a diagnosis of skin and soft tissue infection that
were also coded as having the co-morbidity of obesity was calculated for each of the
three years and a Chi- Square ( χ² ) test was completed to determine if a statistically
significant difference existed among the three years.
Two linear regressions were conducted with Length of Stay and Total Charges as
the dependent variables. A multi-collinearity check was done in order to make sure
there was no significant association or correlation among the variables for each
regression. Several iterations of the regression were run in order to find the significant
variables that explained each of the dependent variables, LOS and Total Charges.
The first LOS model was expressed as:
LOS= f(ageβ1 + femaleβ2 + Medicareβ3 + Medicaidβ4 + PrivatePayβ5 + SelfPayβ6 +
NoChargeβ7 + Whiteβ8 + Blackβ9 + Hispanicβ10 + AsianorPacificβ11 + NativeAmericanβ12 +
ZipQrtl1β13 + ZipQrtl2β14 + ZipQrtl3β15 + ZipQrtl3β16 + ZipQrtl4β17 + cm_arthβ18 +
cm_dmcxβ19 + cm_htn_cβ20 + cm_obeseβ21 + β0 +ε)
The final LOS model used for explanation of the relevant results was expressed as:
LOS= f(ageβ1 + femaleβ2 + Medicareβ3 + Medicaidβ4 + Blackβ9 + ZipQrtl1β13 + ZipQrtl4β17
+ cm_dmcxβ19 + cm_htn_cβ20 + cm_obeseβ21 +β0+ ε)
A similar first model was expressed for Total Charges as the dependent variable:
Total Charges= f(ageβ1 + femaleβ2 + Medicareβ3 + Medicaidβ4 + PrivatePayβ5 + SelfPayβ6
+ NoChargeβ7 + Whiteβ8 + Blackβ9 + Hispanicβ10 + AsianorPacificβ11 + NativeAmericanβ12
+ ZipQrtl1β13 + ZipQrtl2β14 + ZipQrtl3β15 + ZipQrtl3β16 + ZipQrtl4β17 + cm_arthβ18 +
cm_dmcxβ19 + cm_htn_cβ20 + cm_obeseβ21 + β0 +ε)
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The final Total Charges model used for explanation of the relevant results was expressed
as:
Total Charges =f(ageβ1 + femaleβ2 + Medicareβ3 + Medicaidβ4 + PrivatePayβ5 + SelfPayβ6
+ Whiteβ8 + Blackβ9 + ZipQrtl1β13 + ZipQrtl4β17 + + cm_dmcxβ19 + cm_htn_cβ20 +
cm_obeseβ21 + β0 +ε)

Since LOS and Total Charges do not have a normal distribution, a linear
regression is not the most accurate model to use. A more accurate model would use
the log of the dependent variable in order to compensate for the skewed data.
However, some of the data points for LOS were 0 and therefore, a log-transformation of
the dependent variable was not possible.

V. Results
Characteristics of the sample used for this research are presented in Table 2.
Each observation is one hospital admission. The number of observations for patients
admitted to hospitals with skin and soft tissue infections is over 100,000 for each of the
three years, thus providing a large sample size for this research project.
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Table 2: Descriptive statistics for each of the three years of data (2003, 2005, 2007)
2003
# of Observations
Avg. Length of Stay (days)
Avg. Total Charges (dollars)
Avg. Age (years)
Male (%)
Female (%)
Medicare (%)
Medicaid (%)
Private Pay/HMO (%)
Self Pay (%)
White (%)
Black (%)
Lower Income
Zip Qrtl 1 (%)
Higher Income
Zip Qrtl 4 (%)
Co-Morbidity: Diabetes uncomplicated
(%)
Co-Morbidity: Diabetes with chronic
complications (%)
Co-Morbidity: Hypertension (%)
Co-Morbidity: Obesity (%)

103,987
6.2
$19,774
56.58
42,517
(40.89%)
61,466
(59.11%)
50,536
(48.77%)
14,394
(13.89%)
29,372
(28.25%)
5,127
(4.93%)
37,865
(71.05%)
14,244
(26.73%)
41,064
(40.83%)
8,611
(8.56%)
27,712
(26.65%)
7,655
(7.36%)
49,754
(47.85%)
49,459
(47.56%)
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2005
118,724
6.19
$23,715
54.51
48,707
(41.03%)
70,013
(58.97%)
54,924
(46.42%)
18,839
(15.92%)
32,172
(27.1%)
7,978
(6.72%)
35,477
(73.78%)
11,815
(24.57%)
49,746
(43.30%)
8,595
(7.48%)
30,141
(25.39%)
8,449
(7.12%)
57,284
(48.25%)
55,617
(46.85%)

2007
117,292
6.29
$26,501
54.31
48,190
(41.06%)
69,134
(58.94%)
53,190
(45.76%)
17,846
(15.35%)
32,093
(27.36%)
8,497
(7.24%)
30,782
(70.03%)
11,800
(26.84%)
54,706
(48.19%)
9,783
(8.62%)
31,688
(27.02%)
8,908
(7.59%)
59,199
(50.47%)
59,139
(50.42%)

The percent of admissions for skin and soft tissue infection that were also coded
for obesity decreased for the year 2005 (46.85%) from the year 2003 (47.56%), but
increases for the year 2007 (50.42%). The overall percentage of patients coded for the
co-morbidity of obesity for all three years was 48.3%.

Chart 1: Number of People Admitted
with Skin and Soft Tissue Infections for
Each Year

Number of People Admitted to Hospital
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80000
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Chart 2: Percentage of People Admitted
for Skin and Soft Tissue Infections that
are Obese by Year
120
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20
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A Chi- Square ( χ² ) test was performed to test the null hypothesis that there
were no differences among the three years proportions of admissions that were coded
as having a co-morbidity of obesity. The results from STATA are presented in Table 3.
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Table 3: Chi-Squared Analysis for the proportion of people hospitalized with skin and
soft tissue infections that were also coded as obese (0=not obese, 1=obese) for each
year (2003, 2005, and 2007)
Key

frequency
chi2 contribution

cm_obese

2003

YEAR
2005

2007

Total

0

54,528
10.9

63,107
48.4

58,153
102.2

175,788
161.5

1

49,459
11.6

55,617
51.9

59,139
109.4

164,215
172.9

Total

103,987
22.5

118,724
100.3

117,292
211.5

340,003
334.4

Pearson chi2(2) = 334.3763

Pr = 0.000

Since the computed test statistic (χ² =334.3763) is greater than the critical value
(5.991) the null hypothesis is rejected. As such, it can be concluded that there is a
statistically significant difference in the proportion of patients admitted with a comorbidity of obesity for the three years in the data set.
A linear regression using all three years of data (2003, 2005, 2007) was used to
predict Length of Stay (dependent variable). All variables that were not statistically
significant were dropped and resulted in the following equation:
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LOS= f( 0.0342age - 0.4245female + 1.103Medicare + 1.381Medicaid + 1.257Black 0.1657ZipQrtl1+ .104ZipQrtl4 + 0 .884cm_dmcx - 0.835 cm_htn_c - 2.65cm_obese
+5.419+ ε)

Refer to Table 4 for the regression analysis using length of stay as the dependent
variable.

Table 4: Linear Regression Analysis for Length of Stay as the Dependent Variable
Independent
Coefficient Standard
Variable
Error
Age
0.034
0.0008
Female
-0.424
0.0273
Medicare
1.103
0.0352
Medicaid
1.381
0.0413
Black
1.257
0.0432
Lower income
-0.165
0.0277
level (ZipQrtl1)
Higher income
0.104
0.051
level (ZipQrtl4)
Diabetes
0.884
0.051
comorbidity
Hypertension
-0.835
0.028
comorbidity
Obesity
-2.654
0.027
comorbidity
Constant
5.419
0.051
Number of Observations 339,968
F(10,339957)
2180.08
Prob > F
0.000
R-squared
0.0603
Adjusted R-squared
0.0602
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t-value

P>|t|

38.43
-15.52
31.31
33.39
29.72
-5.97

0.000
0.000
0.000
0.000
0.000
0.000

95% confidence
interval
(0.032, 0.036)
(-0.478, -0.37)
(1.034, 1.172)
(1.3, 1.462)
(1.174, 1.34)
(-0.2201, -0.1113)

2.07

0.038

(0.0055, 0.2041)

17.3

0.000

(0.784, 0.984)

-29.83

0.000

(-0.89, -0.78)

-94.91

0.000

(-2.709, -2.599)

106.09

0.000

(5.319, 5.519)

In this regression model four variables (gender, lower income (zipQrtl1), comorbidities of hypertension and obesity) predict a decrease in the length of stay while
six variables (Age, Medicare, Medicaid, Black, higher income (ZipQrtl4) and co-morbidity
of diabetes with complications) predict an increase the length of stay. The r-squared for
this regression is 0.0603. This indicates that 6.03% of the variation in length of stay is
explained by this set of independent variables. This seems low, but given the
complexity of hospital length of stay and the simplicity of this model, it is acceptable.
A linear regression using all three years of data was used to predict Total Charges
(dependent variable) and resulted in the following equation:
Total Charges =f ( 94age - 3087female - 1101Medicare - 845Medicaid - 649PrivatePay
- 5355SelfPay + 1474 White + 4521Black - 2220ZipQrtl1 + 1995ZipQrtl4 + 1347cm_dmcx 935 cm_htn_c - 4298 cm_obese + 23472 +ε)

Refer to Table 5 for the regression analysis using Total Charges as the dependent
variable.
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Table 5: Linear Regression Analysis for Total Charges as the Dependent Variable
Independent
Coefficient Standard
Variable
Error
Age
94.70
4.111
Female
-3087.30
125.989
Medicare
-1101.44
315.492
Medicaid
-845.52
331.933
Private
-649.86
311.960
Pay/HMO
Self Pay
-5355.96
377.717
White
1474.99
136.590
Black
4521.03
200.710
Lower income
-2220.18
128.107
level (ZipQrtl1)
Higher income
1995.34
232.616
level (ZipQrtl4)
Diabetes
1347.91
235.417
comorbidity
Hypertension
-935.69
128.840
comorbidity
Obesity
-4298.25
128.778
comorbidity
Constant
23472.34
360.869
Number of Observations 334,998
F( 13,334984)
363.27
Prob > F
0.000
R-squared
0.0139
Adjusted R-squared
0.0139

t-value

P>|t|

95% confidence
interval
(86.64, 102.76)
(-3334.2, -2840.36)
(-1719.8, -483.09)
(-1496.1, -194.94)
(-1261.2, -38.43)

23.04
-24.50
-3.49
-2.55
-2.08

0.000
0.000
0.000
0.011
0.037

-14.18
10.80
22.53
-17.33

0.000
0.000
0.000

(-6096.2, -4615.64)
(1207.2, 1742.7)
(4127.6, 4914.4)
(2471.2, -1969.1)

8.558

0.000

(1539.4, 1461.2)

5.73

0.000

(886.4, 1809.3)

-7.26

0.000

(-1188.2, -683.17)

-33.38

0.000

(-4550.6, -4045.8)

65.04

0.000

(22765, 24179.6)

More of the data elements were statistically significant independent variables in
the regression for Total Charges than in the regression analysis for Length of Stay.
Overall, eight variables have a negative predictive value for total charges (gender,
Medicare, Medicaid, Private Pay/HMO, Self Pay, lower income (ZipQrtl1), co-morbidities
of hypertension and obesity) and five variables have a positive predictive value for total
charges (age, white, black, higher income (ZipQrtl4) and co-morbidity of diabetes with
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complications). All of the payer sources decrease the predicted value of total charges to
varying degrees while the subcategories of race (white, black) both increase the
predicted value for total charges. The r-squared for this regression model is 0.0139
indicating that 1.39% of the variation in total hospital charges is explained by the
independent variables in this regression analysis. As in the Length of Stay regression,
this r-squared value is low but not unexpected.
The regression analysis revealed some very interesting results for Length of Stay
and for Total Charges. Most surprising is the finding that obesity has a negative
predictive value for Length of Stay and for Total hospital Charges which seems
counterintuitive. The hypothesis was that a co-morbidity of obesity would increase
Length of Stay and Total Charges due to the added complications and poorer healing of
skin and soft tissue infections in this population. However, neither regression model
supports that hypothesis. For the Length of Stay regression with all other variables held
constant, a co-morbidity of obesity decreases the LOS by 2.65 days. This is a statistically
significant decrease with a p-value of less than 0.001. Given that the average Length of
Stay is about 6.2 days a decrease of 2.65 days will definitely have an impact on hospital
costs. This is seen in the Total Charges regression that with all other variables held
constant, the co-morbidity of obesity decreases total hospital charges by $4,292.
Not surprisingly, increasing age will increase length of stay, most probably due to
older people having more advanced disease states requiring more complicated
treatments. Holding all other variables constant, every 1 year of age adds 0.03 days to
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length of stay and $94 to total hospital charges. Being a women decreases length of stay
by almost a half a day (.424 days) and it also reduces the total hospital charges by
$3,087.
Living in ZipQrt 1 (a proxy for lower income level) decreases length of stay by
.165 days. This is due to the effect of income independent of Medicaid. If these people
do not have Medicaid, then they stay in the hospital for a shorter period of time. But, if
they have Medicaid (an income based health insurance) as the payer source, then the
length of stay increases by 1.38 days. Living in a more affluent community as indicated
by ZipQrt4 predicts an increase in total charges by $1,995 and an increase in length of
stay by 0.104 days.
Race also impacts the length of stay. Being Caucasian does not have a
statistically significant impact on the Length of Stay regression where as being black
increases length of stay by one and a quarter days. However, for Total Charges, being
Caucasian is statistically significant and predicts an increase in total charges by $1,474
while being Black increases total charges by $4,521 per hospital admission.
The only co-morbidity that has a positive predictive value in Length of Stay and
Total Charges is diabetes (with chronic complications). For each regression the p-value is
less than 0.001 for this co-morbidity. And while having chronic complications for
diabetes will increase length of stay by almost a day, having hypertension decreases
length of stay by almost the same amount. Both of the co-morbidities for hypertension
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and obesity have a negative predictive value for length of stay and total hospital
charges.
Another difference between the two regressions is the payer source. While
private pay/HMO and self pay were not statistically significant for Length of Stay they
were both statistically significant for Total Charges (p-value 0.037 and <0.000
respectively).
There is some agreement between these two regression analyses as to what
decreases length of stay and also decreases total hospital charges: female gender, lower
income and co-morbidities of hypertension and obesity. Age, black race, higher income,
and co-morbidity of diabetes with complications all increase length of stay and total
hospital charges.
However, other variables predict opposing directions in the two models. For
example, Medicare and Medicaid both increase length of stay but also, both decrease
total charges. In fact, all of the payer sources decrease the predicted total charges. This
can be explained by noting that the y-intercept for the Total Charges regression is
$23,472. If you consider that among the payer sources, Medicaid subtracts less than
Medicare from this value (-$845 vs. -$1,101), then it is reasonable to think that it
subtracts less because the patients are in the hospital longer. This is supported by the
Length of Stay regression where Medicaid predicts an increase in length of stay by 1.38
days vs. 1.1 days for Medicare.
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VI. Discussion
The percentage of people admitted to the hospital for a skin and soft tissue
infection that also have a co-morbidity of obesity changed for the three years of data.
In 2003, the percentage was 47.56% and this dropped slightly to 46.85% in 2005 but
then rose to 50.42% in 2007. As the χ² test indicates, this is a statistically significant
difference in the proportions. So, while the obesity prevalence has not measurably
increased in the past few years nationally, the obesity prevalence in patients admitted
with skin and soft tissue infections has increased for this population. This would seem
to indicate that obesity is continuing to play a greater role in patients who have skin and
soft tissue infections that require admission to hospitals. And, given that about 50% of
these patients are coded as having a co-morbidity of obesity, this could be an important
relationship to investigate in future research.
The percentage of people who are obese in this population is greater than the
national average for each of the three years and is also greater than individual state
averages of 29.8% in KY, in 29.0% NC, 30.1% in SC, 30.6% in TN, 31.2% in WV for the
year 2008.12 This data suggests that among people with skin and soft tissue infections a
greater percentage of them are also obese as compared to the general population. This
may indicate that obesity increases the chance that a person may require hospitalization
for a skin and soft tissue infection but a definitive answer to that question is beyond the
scope of this research project. Further research into the causal relationship between
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obesity and skin and soft tissue infections would be able to address that question more
fully.

Table 6: Percent of people hospitalized with skin and soft tissue infections that are also
obese for each state for all three years of data combined (2003, 2005 and 2007)
State
Co-Morbidity of Obese
No
Yes
Percent Obese in each state

GA
41,501
41,748
50.14%

KY
23,694
22,237
48.41%

NC
45,580
44,508
49.4%

SC
16,324
15,838
49.2%

TN
33,771
27,402
44.79%

WV
14,918
12,482
45.55%

VII. Limitations
There are several limitations of this research project. Each regression analysis
used a simple linear regression which is not the most appropriate regression to use
since Length of Stay and Total Charges do not have a normal distribution. A more
accurate model would use a log-transformation of the dependent variable. Also, only a
few variables (age, gender, payer source, race, a proxy for income level and comorbidities) were used as independent variables. There are many more variables that
are involved in length of stay and in the total hospital charges that are not reflected in
this data analysis.
The ICD-9 codes that were used for skin and soft tissue infections cover a broad
range of types and severity of infection. For example, the ICD-9 code 682 is for “other
cellulitis and abscess” and can be further specified by location but nothing in the code
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suggests the causal organism of the cellulitis or the severity of the infection or whether
or not the patient has an abscess or has cellulitis.
Also, the proxy used for a patient’s income level in this data is the median
household income quartiles for the patient’s zip code which introduces some
inaccuracies since it is grouping the income level for the patients by the geographic area
of the zip code and assigning the median income level for that whole group.
Another limitation is that this research project only used data from three years
that covers a range of five years from 2003 to 2007. This may not be enough time to
capture the subtleties of the changes in obesity prevalence in this population.
Lastly, the information in this data set depends on the voluntary reporting by
hospitals and the ICD-9 codes are taken from patient discharge abstracts. This
introduces the possibility of inconsistent reporting and coding differences by different
hospitals which may have affected the results of the analysis.

VIII. Recommendations for Future Studies
This project has been an opportunity to delve into the complex relationship
between obesity and skin and soft tissue infections, but it has only just begun to tease
out some of the information imbued in this data set. The societal impact of obesity in
relation to other disease states like diabetes or hypertension has received more
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research attention, but this relationship is an area ripe with research possibilities as
well. This study has identified some interesting questions for future research. For
example: are the types of infections that people who obese are admitted for different
or more severe than the types of infections for which non-obese people are admitted?
Is there a difference in the proportion of people admitted for skin and soft tissue
infection who are also obese in different regions of the country? Further research into
obesity and skin and soft tissue infections would be advised due to the health, economic
and policy implications in our general population. As our nation struggles with the cost
of healthcare and the best way in which to deliver the care, the policy implications
involved in obesity are riveting.
It seems that the current laws and policies aimed at preventing or reducing
obesity may be having a positive impact given that the latest data from NHANES
concludes that obesity rates have leveled off nationally. I think that it is important for
our society to consider how involved our government should be in our individual health
choices. Since obesity is predominantly a result of greater calories consumed than
expended, and eating is a necessary function for life (unlike tobacco or alcohol), how
does a government try to improve the individual choices a person makes about what to
eat for lunch?
In 2007, the National Cancer Institute (NCI) convened a meeting to discuss
priorities for a research agenda to inform obesity policy and in 2009 this group issued a
“call to action” to the research community to investigate public policy to effect
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structural change in order to alter population-level diet and physical activity
behavior.27,28
There is already some public policy legislation focused on the obesity issue at the
federal, state and local levels of government. The Food, Conservation and Energy Act of
2008 provides $1.3 billion in new funding over ten years for growing fruits, vegetables
and nuts. It also provides vouchers for low-income seniors to purchase fruits and
vegetables from local farmers and it provides about $500 million for states to provide a
fresh fruit or vegetable snack in schools.29 Kentucky enacted legislation that limits the
beverages available in schools to water, 100% juice drinks, low-fat milk and beverages
with no more than ten grams of sugar per serving.30 Indiana passed a statute requiring
daily physical activity in all elementary schools.31 And, New York City’s Department of
Health and Mental Hygiene implemented a rule mandating that day care services offer
at least sixty minutes of activity and limiting video viewing to educational programs. 32
The most recent federal legislation, Patient Protection and Affordable Care Act,
requires calorie and content be displayed next to the menu items in fast-food and chain
restaurants. It also includes the formation of a National Prevention, Health Promotion
and Public Health Council that has the mandate to provide recommendations to the
President and Congress about changes in federal policy regarding sedentary behavior.33
As such, the more that is known about the impact of obesity (a result of sedentary
behavior) in regards to health, the better informed such policies may be.
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Appendix I: Tables

Table 7: Number of observations for each state for all three years combined

Hospital State Number of Observations Percentage of Observations
GA
KY
NC
SC
TN
WV

83,249
45,931
90,088
32,162
61,173
27,400

24.48%
13.51%
26.50%
9.46%
17.99%
8.06%

Total

340,003

100%
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